| Literature DB >> 31097002 |
Wei-Liang Chen1, Yan Wang2, Bin Zhou2, Juan-Kun Liao2, Rui Chen2.
Abstract
BACKGROUND: The reconstruction of through-and-through cheek defects involving the labial commissure following cancer ablation is a surgical challenge.Entities:
Keywords: Abbe–Estlander flap; Buccal squamous cell carcinoma; Cheek defect; Pectoralis major muscle flap; Pedicle flaps; Supraclavicular flap; Trapezius myocutaneous flap
Mesh:
Year: 2019 PMID: 31097002 PMCID: PMC6521464 DOI: 10.1186/s13005-019-0196-6
Source DB: PubMed Journal: Head Face Med ISSN: 1746-160X Impact factor: 2.151
Demographics, clinical characteristics, and outcomes of the A-EF, SFIF, PMMF, and TIMF for reconstructing through-and-through cheek defects involving the labial commissure following cheek cancer ablation in 35 patients with buccal squamous cell carcinoma
| A-EF ( | SFIF ( | PMMF ( | TIMF ( | ||
|---|---|---|---|---|---|
| Sex | |||||
| Male | 3 (80.0) | 5 (62.6) | 6 (66.7) | 7 (53.8) | 0.887a |
| Female | 2 (20.0) | 3 (37.4) | 3 (33.3) | 6 (46.2) | |
| Age, years (mean ± SD) | 52.0 ± 8.5 | 64.3 ± 9.2 | 59.6 ± 8.2 | 59.8 ± 12.7 | 0.863a |
| Clinical stage | |||||
| I | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.026b |
| II | 5 (100.0) | 3 (22.5) | 0 (0.0) | 0 (0.0) | |
| III + rCS III | 0 (0.0) | 5 (42.5) | 5 + 1 (66.7) | 1 + 6 (53.8) | |
| IV + rCS IV | 0 (0.0) | 0 (0.0) | 2 + 1 (33.3) | 4 + 2 (46.2) | |
| Treatment | |||||
| TR | 5 (100.0) | 7 (87.5) | 3 (33.3) | 0 (0.0) | 0.036b |
| TR + PM + MM | 0 (0.0) | 1 (12.5) | 5 (55.6) | 8 (61.5) | |
| TR + Man+Max | 0 (0.0) | 0 (0.0) | 1 (11.1) | 5 (38.5) | |
| Flap (cm) | |||||
| Inner dimensions | |||||
| Range, median | 1 × 2 to 2 × 3, 1.8 × 2.2 | 5 × 3 to 7 × 5, 5.5 × 4.3 | 6 × 4 to 7 × 5, 6.3 × 4.5 | 6 × 6 to 15 × 8, 9.8 × 6.7 | 0.041b |
| Outer dimensions | |||||
| Range, median | 2 × 2 to 3 × 5, 1.8 × 3.8 | 5 × 4 to 7 × 8, 5.5 × 4.6 | 6 × 6 to 7 × 6, 6.3 × 6.6 | 6 × 8 to 15 × 20, 9.8 × 13.2 | 0.033b |
| Successful (no.) | 5 (100.0) | 7 (87.5) | 9(100.0) | 13 (100.0) | 0.967a |
| Local complications | |||||
| Hemorrhage | 1 (20.0) | 1 (12.5) | 0 (0.0) | 1 (7.7) | 0.554c |
| Orocutaneous fistula | 0 (0.0) | 1 (12.5) | 0 (0.0) | 0 (0.0) | |
| Dehiscence in donor-site | 0 (0.0) | 0 (0.0) | 1 (11.1) | 2 (15.4) | |
| Esthetic results | |||||
| 1 | 0 (0.0) | 1 (12.5) | 1 (11.1) | 4 (30.8) | 0.039c |
| 2 | 1 (20.0) | 2 (25.0) | 6 (66.7) | 7 (53.8) | |
| 3 | 4 (80.0) | 5 (62.5) | 2 (22.2) | 2 (15.4) | |
| Orbicularis oris function | |||||
| 1 | 0 (0.0) | 1 (12.5) | 2 (22.2) | 4 (30.8) | 0.042c |
| 2 | 0 (0.0) | 1 (12.5) | 4 (44.5) | 6 (46.2) | |
| 3 | 5 (100.0) | 6 (75.0) | 3 (33.3) | 3 (23.0) | |
| Speech function | |||||
| 1 | 0 (0.0) | 0 (0.0) | 2 (22.2) | 5 (38.4) | 0.046c |
| 2 | 0 (0.0) | 2 (25.0) | 3 (33.3) | 6 (46.2) | |
| 3 | 5 (100.0) | 6 (75.0) | 4 (44.5.) | 2 (15.4) | |
| Follow-up range, median (months) | 6–38, 26.8 | 6–36, 25.0 | 6–32, 22.1 | 6–33, 20.8 | 0.829a |
| Status (months) | |||||
| AND | 4 (80.0) | 7 (87.5) | 5 (55.6) | 5 (38.4) | 0.039b |
| AWD | 1 (20.0) | 1 (12.5) | 2 (22.2) | 4 (30.8) | |
| DOD | 0 (0.0) | 0 (0.0) | 2 (22.2) | 4 (30.8) | |
Abbreviations: A-EF Abbe–Estlander flap, SFIF folded extended supraclavicular fasciocutaneous island flap, PMMF pectoralis major muscle flap, TIMF folded extended vertical lower trapezius island myocutaneous flap, rCS clinical staging of recurrence, TR tumor resection, Man mandibulotomy, Max maxillotomy, PM + MM partial maxillotomy plus marginal mandibulotomy, AND alive with no disease, AWD alive with disease, DOD died of disease
a All groups were compared
b The A-EF and SFIF groups were compared with the PMMF and TIMF groups
c The A-EF group was compared with the SFIF, PMMF and TIMF groups
Fig. 1A 45-year-old man with stage II buccal squamous cell carcinoma involving the labial commissure
Fig. 2Defect in the cheek and adjacent oral commissure after tumor resection, with the Abbe–Estlander flap prepared along the nasolabial fold, creating a triangular total-thickness flap, based on the upper labial artery
Fig. 3The postoperative appearance
Fig. 4A 43-year-old man with stage III buccal squamous cell carcinoma involving the labial commissure. The incisions for the folded extended supraclavicular fasciocutaneous island flap (SFIF) and tumor excision have been drawn
Fig. 5A foldable SFIF was created by dissecting the skin in the flap bilaterally
Fig. 6The medial portion of the flap was used for the buccal mucosa and the distal portion was used for the skin of the cheek
Fig. 7The postoperative appearance
Fig. 8A 63-year-old man presented with stage IV buccal squamous cell carcinoma involving the labial commissure
Fig. 9A folded pectoralis major muscle flap was designed
Fig. 10The postoperative appearance
Fig. 11An 81-year-old woman with stage IV recurrent buccal squamous cell carcinoma involving the labial commissure
Fig. 12An extended vertical lower trapezius island myocutaneous flap (TIMF) with a skin paddle measuring (10 + 7) × 7 cm was designed
Fig. 13A foldable TIMF was created and the flap was passed through a tunnel in the upper part of the trapezius muscle
Fig. 14Wide excision of the tumor was made
Fig. 15The distal portion of the flap was turned to serve as the mucosa of the mouth and the medial portion for the skin
Fig. 16The view 3 months after surgery: (a) closed and (b) open mouth